Institutional investors purchased a net $16.4 thousand shares of NEO during the quarter ended September 2016, and now own 58.57% of the total float, a percentage that is typical for companies in the Medical/Nursing Services industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
NEXT CENTURY GROWTH INVESTORS LL... Bought 498.4 Thousand shares of Neogenomics Inc
WILLIAM BLAIR INVESTMENT MANAGEM... Bought 392.0 Thousand shares of Neogenomics Inc
ARROWSTREET CAPITAL LP Bought 280.3 Thousand shares of Neogenomics Inc